Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

被引:56
作者
Eshleman, Amy J. [1 ,2 ,3 ]
Forster, Michael J. [4 ]
Wolfrum, Katherine M. [1 ]
Johnson, Robert A. [1 ]
Janowsky, Aaron [1 ,2 ,5 ]
Gatch, Michael B. [4 ]
机构
[1] Portland VA Med Ctr, Res Serv, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA
[4] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
[5] Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97239 USA
基金
美国国家卫生研究院;
关键词
Substituted phenethylamines; Drug discrimination; Serotonin receptor; Locomotor activity; Lysergic acid diethylamide (LSD); (-)-2,5-dimethoxy-4-methylamphetamine; Drug abuse; LYSERGIC-ACID DIETHYLAMIDE; 5-HT2C RECEPTORS; PHOSPHOLIPASE-C; HALLUCINOGENIC PHENETHYLAMINE; PHOSPHOINOSITIDE HYDROLYSIS; SEROTONIN; 5-HT2A; STIMULUS; AGONIST; MDMA; LSD;
D O I
10.1007/s00213-013-3303-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Psychoactive-substituted phenethylamines 2,5-dimethoxy-4-chlorophenethylamine (2C-C); 2,5-dimethoxy-4-methylphenethylamine (2C-D); 2,5-dimethoxy-4-ethylphenethylamine (2C-E); 2,5-dimethoxy-4-iodophenethylamine (2C-I); 2,5-dimethoxy-4-ethylthiophenethylamine (2C-T-2); and 2,5-dimethoxy-4-chloroamphetamine (DOC) are used recreationally and may have deleterious side effects. This study compares the behavioral effects and the mechanisms of action of these substituted phenethylamines with those of hallucinogens and a stimulant. The effects of these compounds on mouse locomotor activity and in rats trained to discriminate dimethyltryptamine, (-)-DOM, (+)-LSD, (+/-)-MDMA, and S(+)-methamphetamine were assessed. Binding and functional activity of the phenethylamines at 5-HT1A, 5-HT2A, 5-HT2C receptors and monoamine transporters were assessed using cells heterologously expressing these proteins. The phenethylamines depressed mouse locomotor activity, although 2C-D and 2C-E stimulated activity at low doses. The phenethylamines except 2C-T-2 fully substituted for at least one hallucinogenic training compound, but none fully substituted for (+)-methamphetamine. At 5-HT1A receptors, only 2C-T-2 and 2C-I were partial-to-full very low potency agonists. In 5-HT2A arachidonic acid release assays, the phenethylamines were partial to full agonists except 2C-I which was an antagonist. All compounds were full agonists at 5-HT2A and 5-HT2C receptor inositol phosphate assays. Only 2C-I had moderate affinity for, and very low potency at, the serotonin transporter. The discriminative stimulus effects of 2C-C, 2C-D, 2C-E, 2C-I, and DOC were similar to those of several hallucinogens, but not methamphetamine. Additionally, the substituted phenethylamines were full agonists at 5-HT2A and 5-HT2C receptors, but for 2C-T-2, this was not sufficient to produce hallucinogen-like discriminative stimulus effects. Additionally, the 5-HT2A inositol phosphate pathway may be important in 2C-I's psychoactive properties.
引用
收藏
页码:875 / 888
页数:14
相关论文
共 51 条
[1]   Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors [J].
Acuña-Castillo, C ;
Villalobos, C ;
Moya, PR ;
Sáez, P ;
Cassels, BK ;
Huidobro-Toro, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (04) :510-519
[2]  
[Anonymous], 2003, GUIDELINES CARE USE
[3]   Agonist-directed signaling of serotonin 5-HT2C receptors:: Differences between serotonin and lysergic acid diethylamide (LSD) [J].
Backstrom, JR ;
Chang, MS ;
Chu, H ;
Niswender, CM ;
Sanders-Bush, E .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S77-S81
[4]  
BAKER LE, 1995, BEHAV PHARMACOL, V6, P263
[5]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[6]   Recurrent Seizures and Serotonin Syndrome Following 2C-I" Ingestion" [J].
Bosak A. ;
LoVecchio F. ;
Levine M. .
Journal of Medical Toxicology, 2013, 9 (2) :196-198
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   PSYCHOTOMIMETIC AGENTS [J].
COHEN, S .
ANNUAL REVIEW OF PHARMACOLOGY, 1967, 7 :301-+
[9]   A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs [J].
de Boer, D ;
Bosman, I .
PHARMACY WORLD & SCIENCE, 2004, 26 (02) :110-113
[10]   2C or Not 2C: Phenethylamine Designer Drug Review [J].
Dean B.V. ;
Stellpflug S.J. ;
Burnett A.M. ;
Engebretsen K.M. .
Journal of Medical Toxicology, 2013, 9 (2) :172-178